News from the MCRC
Discover Magazine
28/05/2025
The Hidden Cancer: Cancer of Unknown Primary
Discover more about CUPID, a machine learning tool to identify cancers of unknown primary affecting around 8,100 people per year
Discover Magazine
28/05/2025
Kathy’s Story
Read Kathy's story sharing her journey from diagnosis to treatment of a rare vaginal cancer
Discover Magazine
28/05/2025
Inside the MCRC Biobank
Discover more about the MCRC Biobank, including how patient samples are collected, processed and used in research.
Discover Magazine
28/05/2025
Clinical Trials: The 5Ws
Discover Magazine
28/05/2025
BRAINATOMY-Leveraging the Cancer Team Science Approach
An example of Team Science, discover more about BRAINatomy, an innovative data-driven study aimed at improving the long term outcomes for children diagnosed with brain tumours.
Discover Magazine
28/05/2025
Team Science at the Manchester Cancer Research Centre
Alumni Stories
16/05/2025
Meet Professor Fiona Thistlethwaite
Fiona became a consultant at The Christie in 2007 and her academic focus is clinical trial development in immunotherapy and adoptive T-cell therapy.
MCRC Blog
13/05/2025
Ca-PRI 2025: A Global Gathering on Cancer Innovation, Inequality, and Interdisciplinary Care
MCRC Blog
12/05/2025
ESTRO 2025: Manchester research highlights
In our look back at ESTRO 2025, we summarise the Manchester researchers and celebrate the incredible showing of radiotherapy related research shown at the international conference.
Director's Update
21/03/2025
MCRC Director’s Update – March 2025
Partner News
21/03/2025
Professors David French and Peter Hoskin appointed as NIHR Senior Investigators
NIHR Senior Investigators recognise those who make a significant impact on health and care.
Training and Development
18/03/2025
North West Cancer Research Funds Three New PhD Projects in Manchester
MCRC Blog
06/03/2025
International Women’s Day 2025: Women in Cancer Research
Saturday 8th March marks International Women’s Day – a time to celebrate the achievements of women across all fields, including science and research.
Impact Case Study
Pseudomyxoma peritonei (PMP)
This impact case study covers three areas in which our team in Manchester have progressed the understanding of AMNs as tumours and PMP as a disease.
